Background/Aims: Magnetic resonance imaging (MRI) is used to investigate the etiology of growth hormone deficiency (GHD). This study examined relationships between MRI findings and clinical/hormonal phenotypes in children with GHD in the observational Genetics and Neuroendocrinology of Short Stature International Study, GeNeSIS. Methods: Clinical presentation, hormonal status and first-year GH response were compared between patients with pituitary imaging abnormalities (n = 1,071), patients with mutations in genes involved in pituitary development/GH secretion (n = 120) and patients with idiopathic GHD (n = 7,039). Results: Patients with hypothalamic-pituitary abnormalities had more severe phenotypes than patients with idiopathic GHD. Additional hormonal deficiencies were found in 35% of patients with structural abnormalities (thyroid-stimulating hormone > adrenocorticotropic hormone > luteinizing hormone/follicle-stimulating hormone > antidiuretic hormone), most frequently in patients with septo-optic dysplasia (SOD). Patients with the triad [ectopic posterior pituitary (EPP), pituitary aplasia/hypoplasia and stalk defects] had a more severe phenotype and better response to GH treatment than patients with isolated abnormalities. The sex ratio was approximately equal for patients with SOD, but there was a significantly higher proportion of males (approximately 70%) in the EPP, pituitary hypoplasia, stalk defects, and triad categories. Conclusion: This large, international database demonstrates the value of classification of GH-deficient patients by the presence and type of hypothalamic-pituitary imaging abnormalities. This information may assist family counseling and patient management.

1.
Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL, Chernausek SD, Savage MO, Wit JM: Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 2008;93:4210-4217.
2.
Growth Hormone Research Society: Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000;85:3990-3993.
3.
Rajab A, Kelberman D, de Castro SC, Biebermann H, Shaikh H, Pearce K, Hall CM, Shaikh G, Gerrelli D, Grueters A, Krude H, Dattani MT: Novel mutations in LHX3 are associated with hypopituitarism and sensorineural hearing loss. Hum Mol Genet 2008;17:2150-2159.
4.
Alatzoglou KS, Dattani MT: Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev 2009;85:705-712.
5.
Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT: Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 2009;30:790-829.
6.
Murray PG, Hague C, Fafoula O, Gleeson H, Patel L, Banerjee I, Raabe AL, Hall CM, Wright NB, Amin R, Clayton PE: Likelihood of persistent GH deficiency into late adolescence: relationship to the presence of an ectopic or normally sited posterior pituitary gland. Clin Endocrinol 2009;71:215-219.
7.
Romero CJ, Pine-Twaddell E, Radovick S: Novel mutations associated with combined pituitary hormone deficiency. J Mol Endocrinol 2011;46:R93-R102.
8.
Wilson TA, Rose SR, Cohen P, Rogol AD, Backeljauw P, Brown R, Hardin DS, Kemp SF, Lawson M, Radovick S, Rosenthal SM, Silverman L, Speiser P: Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003;143:415-421.
9.
Tsai SL, Laffan E, Lawrence S: A retrospective review of pituitary MRI findings in children on growth hormone therapy. Pediatr Radiol 2012;42:799-804.
10.
Mehta A, Hindmarsh PC, Mehta H, Turton JP, Russell-Eggitt I, Taylor D, Chong WK, Dattani MT: Congenital hypopituitarism: clinical, molecular and neuroradiological correlates. Clin Endocrinol 2009;71:376-382.
11.
Li G, Shao P, Sun X, Wang Q, Zhang L: Magnetic resonance imaging and pituitary function in children with panhypopituitarism. Horm Res Paediatr 2010;73:205-209.
12.
Maghnie M, Ghirardello S, Genovese E: Magnetic resonance imaging of the hypothalamus-pituitary unit in children suspected of hypopituitarism: who, how and when to investigate. J Endocrinol Invest 2004;27:496-509.
13.
Osorio MG, Marui S, Jorge AA, Latronico AC, Lo LS, Leite CC, Estefan V, Mendonca BB, Arnhold IJ: Pituitary magnetic resonance imaging and function in patients with growth hormone deficiency with and without mutations in GHRH-R, GH-1, or PROP-1 genes. J Clin Endocrinol Metab 2002;87:5076-5084.
14.
Binder G, Nagel BH, Ranke MB, Mullis PE: Isolated GH deficiency (IGHD) type II: imaging of the pituitary gland by magnetic resonance reveals characteristic differences in comparison with severe IGHD of unknown origin. Eur J Endocrinol 2002;147:755-760.
15.
Kim SS, Kim Y, Shin YL, Kim GH, Kim TU, Yoo HW: Clinical characteristics and molecular analysis of PIT1, PROP1, LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging. Horm Res 2003;60:277-283.
16.
Dutta P, Bhansali A, Singh P, Rajput R, Bhadada S: Clinico-radiological correlation in childhood hypopituitarism. Indian Pediatr 2010;47:615-618.
17.
Blum WF, Schweizer R: Insulin-like growth factors and their binding proteins; in Ranke MB (ed): Diagnostics of Endocrine Function in Children and Adolescents, ed 3. Basel, Karger, 2003, pp 166-199.
18.
Boettcher C, Schaefer M, Wudy SA, Blum WF: Cross-calibration of IGF-I and IGFBP-3 assays to obtain comparable values. Horm Res 2006;65(suppl 4):178.
19.
Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL: Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
20.
Suwa S, Tachibana K: Standard growth charts for height and weight of Japanese children from birth to 17 years based on a cross-sectional survey of national data. Clin Pediatr Endocrinol 1993;2:87-97.
21.
Preece MA: Evaluation of growth and development; in Holliday MA, Barratt TM, Avner ED, Kogan BA (eds): Pediatric Nephrology, ed 3. Baltimore, Williams and Wilkins, 1994, pp 378-396.
22.
Cole TJ: A chart to link child centiles of body mass index, weight and height. Eur J Clin Nutr 2002;56:1194-1199.
23.
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML, Endocrine Society: Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1587-1609.
24.
Badaru A, Wilson DM: Alternatives to growth hormone stimulation testing in children. Trends Endocrinol Metab 2004;15:252-258.
25.
Triulzi F, Scotti G, di Natale B, Pellini C, Lukezic M, Scognamiglio M, Chiumello G: Evidence of a congenital midline brain anomaly in pituitary dwarfs: a magnetic resonance imaging study in 101 patients. Pediatrics 1994;93:409-416.
26.
Webb EA, Dattani MT: Septo-optic dysplasia. Eur J Hum Genet 2010;18:393-397.
27.
Davis SW, Castinetti F, Carvalho LR, Ellsworth BS, Potok MA, Lyons RH, Brinkmeier ML, Raetzman LT, Caminci P, Mortensen AH, Hayashizaki Y, Arnhold IJ, Mendonca BB, Brue T, Camper SA: Molecular mechanisms of pituitary organogenesis: in search of novel regulatory genes. Mol Cell Endocrinol 2010;323:4-19.
28.
Reynaud R, Gueydan M, Saveanu A, Vallette-Kasic S, Enjalbert A, Brue T, Barlier A: Genetic screening of combined pituitary hormone deficiency: experience in 195 patients. J Clin Endocrinol Metab 2006;91:3329-3336.
29.
Obermannova B, Pfaeffle RW, Zygmunt-Gorska A, Starzyk J, Verkauskiene R, Smetanina N, Bezlepkina O, Peterkova V, Frisch H, Cinek O, Child CJ, Blum WF, Lebl J: Mutations and pituitary morphology in a series of 82 patients with PROP1 gene defects. Horm Res Paediatr 2011;76:348-354.
30.
Maghnie M, Lindberg A, Koltowska-Häggström M, Ranke MB: Magnetic resonance imaging of central nervous system in 15,043 children with growth hormone deficiency in KIGS (Pfizer International Growth Database). Eur J Endocrinol 2013;168:211-217.
31.
Argyropoulou M, Perignon F, Brunelle F, Brauner R, Rappaport R: Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatr Radiol 1991;21:247-249.
32.
Takano K, Utsunomiya H, Ono H, Ohfu M, Okazaki M: Normal development of the pituitary gland: assessment with three-dimensional MR volumetry. AJNR Am J Neuroradiol 1999;20:312-315.
33.
Leger J, Danner S, Simon D, Garel C, Czernichow P: Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood? J Clin Endocrinol Metab 2005;90:650-656.
34.
Louvel M, Marcu M, Trivin C, Souberbielle J-C, Brauner R: Diagnosis of growth hormone (GH) deficiency: comparison of pituitary stalk interruption syndrome and transient GH deficiency. BMC Pediatr 2009;9:29.
35.
McCabe MJ, Gaston-Massuet C, Tziaferi V, Gregory LC, Alatzoglou KS, Signore M, Puelies E, Gerrelli D, Farooqi IS, Raza J, Walker J, Kavanaugh SI, Tsai PS, Pitteloud N, Martinez-Barbera JP, Dattani MT: Novel FGF8 mutations associated with recessive holoprosencephaly, craniofacial defects, and hypothalamo-pituitary dysfunction. J Clin Endocrinol Metab 2011;96:E1709-E1718.
36.
Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Limal JM: Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. J Clin Endocrinol Metab 2001;86:4649-4654.
37.
Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M: Utah Growth Study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 1994;125:29-35.
38.
Stochholm K, Gravholt CH, Laursen T, Jørgensen JO, Laurberg P, Andersen M, Kristensen O, Feldt-Rasmussen U, Christiansen JS, Frydenberg M, Green A: Incidence of GH deficiency - a nationwide study. Eur J Endocrinol 2006;155:61-71.
39.
Grimberg A, Stewart E, Wajnrajch P: Gender of pediatric recombinant human growth hormone recipients in the United States and globally. J Clin Endocrinol Metab 2008;93:2050-2056.
40.
Hughes IP, Choong CS, Cotterill AM, Harris M, Davies PS: Gender bias in children receiving growth hormone treatment. J Clin Endocrinol Metab 2010;95:1191-1198.
41.
Woods KS, Cundall M, Turton J, Rizzoti K, Mehta A, Palmer R, Wong J, Chong WK, Al-Badge R, Woodward KJ, Dattani MT: Over- and underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 2005;76:833-849.
42.
Wang CL, Liang L, Shen Z, Zou CC, Fu JF, Dong GP: X-linked recessive combined pituitary hormone deficiency is mapped to Xp22.3-Xp11 in a Chinese family. Genomics 2011;98:440-444.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.